Pharmacists
Partnering With PGx

advancing-precision PGx for Pharmacists

Pharmacists
Partnering With PGx

advancing-precision PGx for Pharmacists

Pharmacists and Pharmacogenomics

Pharmacogenomics (PGx) is an emerging field that combines the study of genetics with the science of drug delivery. Pharmacogenetics, a similar field, is the study of inherited genetic variations in drug metabolic pathways that can affect how an individual responds to drugs. Since everyone responds differently to medication, PGx testing can help predict how a patient may respond to drug therapy based on their DNA. Pharmacists, because of their specialized training, are in a unique position to help patients, physicians, and other healthcare professionals to understand the benefits of using PGx testing and to provide guidance on reports.

Benefits_PGx_Test--e1552595608996 PGx for Pharmacists

Pharmacogenomics (PGx) is an emerging field that combines the study of genetics with the science of drug delivery. Pharmacogenetics, a similar field, is the study of inherited genetic variations in drug metabolic pathways that can affect how an individual responds to drugs. Since everyone responds differently to medication, PGx testing can help predict how a patient may respond to drug therapy based on their DNA. Pharmacists, because of their specialized training, are in a unique position to help patients, physicians, and other healthcare professionals to understand the benefits of using PGx testing and to provide guidance on reports.

PGx Partnering with Pharmacists

Pharmacists can optimize patient care by incorporating genomics into clinical decision making. PGx testing can help to
reduce the occurrence of adverse drug events, decrease healthcare cost, and improve patient outcomes. Pharmacists can
help bridge the gap between patients and pharmacogenomics testing by explaining the benefits of this new technology.

pharmacist_pgx_icon-e1552594856414 PGx for Pharmacists
Pharmacists are in the unique position to combine PGx information pertaining to drugs with their expertise in pharmacology to provide informed treatment input
for patients.
benefits_of_pgx_testing_icon-e1552594718507 PGx for Pharmacists
By educating patients, physicians, and other healthcare professionals about the benefits of PGx testing, pharmacists can assist in the reducing the frequency of ADRs in patients.
Lesson_Trial_and_Error_icon-e1534349157124 PGx for Pharmacists
Pharmacists can recommend the appropriate dosage adjustments or alternative medication to help benefit the patient.
pharmacist_pgx_testing_icon-e1552594869798 PGx for Pharmacists
Due to their distinctive training, pharmacists are uniquely qualified to help identify the right patient to offer PGx testing to.

Interested in learning more about pharmacogenomics?

PGxOne_Plus_Test_Thumbnail-e1552595246344 PGx for Pharmacists

Read our whitepaper:

The Utility of Pharmacogenomics
Testing in Clinical Practice

Download
PGxOne_Plus_Test_Thumbnail-e1552595246344 PGx for Pharmacists

Read our whitepaper:

The Utility of Pharmacogenomics
Testing in Clinical Practice

Download
PGxOne_Plus_Logo-e1533580098886 PGx for Pharmacists

Admera Health’s PGxOneTM Plus

PGxOneTM Plus is a 50+ genetic test that encompasses over 200 variants and provides actionable recommendations of over 300 drugs spanning 20 therapeutic areas.

How it works

Actionable_Results_graphic PGx for Pharmacists

PGxOneTM Plus provides clear, color coded clinically actionable reports that categorizes over 300 medications spanning over 20 therapeutic areas based on a patient’s DNA profile. Using the latest advancements in Next Generation Sequencing technology, results are ready in 7-10 business days from sample collection to report delivery.

consider_other_alternative50_b PGx for Pharmacists increase_decrease_50 PGx for Pharmacists proceed_with_caution PGx for Pharmacists normal_response_50 PGx for Pharmacists

Consider Alternatives

Dose Recommendation

Proceed With Caution

Normal Response Expected

Download Sample Report

PGxOneTM Plus provides information and recommendations on patients’ medication regimens.
Therapeutic areas most commonly prescribed are:
Select a therapeutic area to learn more:

Cardiology PGx for Pharmacists

Cardiology

Infectious_disease PGx for Pharmacists

Infectious Disease

Oncology PGx for Pharmacists

Oncology

Psychiatry PGx for Pharmacists

Psychiatry/Neurology

pain_managment PGx for Pharmacists

Pain Management

autism PGx for Pharmacists

Autism

Included in the PGxOneTM Plus report is a list of drug interactions for a patient’s current medications, the level of severity and clinical recommendations.

Drug_to_lab_icon PGx for Pharmacists

Drug to Drug

Drug_to_Food_icon PGx for Pharmacists

Drug to Food

drug_by_drug_icon PGx for Pharmacists

Drug to Lab

Drug_To_alcohol_icon PGx for Pharmacists

Drug to Alcohol

The level of severity for drug interactions is reinforced by the level of evidence currently available in the literature.severity_report_icons_key2 PGx for Pharmacists

Actionable_Results_graphic PGx for Pharmacists

PGxOneTM Plus provides clear, color coded clinically actionable reports that categorizes over 300 medications spanning over 20 therapeutic areas based on a patient’s DNA profile. Using the latest advancements in Next Generation Sequencing technology, results are ready in 7-10 business days from sample collection to report delivery.

consider_other_alternative50_b PGx for Pharmacists

Consider Alternatives

increase_decrease_50 PGx for Pharmacists

Dose Recommendation

proceed_with_caution PGx for Pharmacists

Proceed With Caution

normal_response_50 PGx for Pharmacists

Normal Response Expected

Download Sample Report

PGxOneTM Plus provides information and recommendations on patients’ medication regimens.
Therapeutic areas most commonly prescribed are:
Select a therapeutic area to learn more:

Cardiology PGx for Pharmacists

Cardiology

Infectious_disease PGx for Pharmacists

Infectious Disease

Oncology PGx for Pharmacists

Oncology

Psychiatry PGx for Pharmacists

Psychiatry/Neurology

pain_managment PGx for Pharmacists

Pain Management

autism PGx for Pharmacists

Autism

Included in the PGxOneTM Plus report is a list of drug interactions for a patient’s current medications, the level of severity and clinical recommendations.

Drug_to_lab_icon PGx for Pharmacists

Drug to Drug

Drug_to_Food_icon PGx for Pharmacists

Drug to Food

drug_by_drug_icon PGx for Pharmacists

Drug to Lab

Drug_To_alcohol_icon PGx for Pharmacists

Drug to Alcohol

The level of severity for drug interactions is reinforced by the level of evidence currently available in the literature.severity_report_icons_key2 PGx for Pharmacists

Need More Information?

PGxone_Plus_video_icon PGx for Pharmacists

Check out our
Sample Collection
video

Learn more
PGxone_Plus_icon_blue PGx for Pharmacists

Learn more about
our PGxOneTM
Plus test

Learn more
FAQs_page_icon PGx for Pharmacists

More questions?
Check out our Frequently
Asked Questions

Learn more
  1. Kitzmiller, J. P., Groen, D. K., Phelps, M. A. & Sadee, W. Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others. Cleveland Clinic journal of medicine 78, 243-257, doi:10.3949/ccjm.78a.10145 (2011).
  2. Wang, L., McLeod, H. L. & Weinshilboum, R. M. Genomics and drug response. The New England journal of medicine 364, 1144-1153, doi:10.1056/NEJMra1010600 (2011).
  3. Samer, C. F., Lorenzini, K. I., Rollason, V., Daali, Y. & Desmeules, J. A. Applications of CYP450 testing in the clinical setting. Molecular diagnosis & therapy 17, 165-184, doi:10.1007/s40291-013-0028-5 (2013).
  4. Centers for Medicare & Medicaid Services. National Health Accounts Historical. Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NationalHealthAccountsHistorical.html. Accessed January 8, 2019.
  5. Brixner D, Biltaji E, Bress A, et al. The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy. J Med Econ. 2016;19(3):213-28.
  6. Ahmed S, Zhou Z, Zhou J, Chen SQ. Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics Proteomics Bioinformatics. 2016;14(5):298-313.
  7. Patel JN, Wiebe LA, Dunnenberger HM, Mcleod HL. Value of Supportive Care Pharmacogenomics in Oncology Practice. Oncologist. 2018.
  8. Samer, C. F., Lorenzini, K. I., Rollason, V., Daali, Y. & Desmeules, J. A. Applications of CYP450 testing in the clinical setting. Molecular diagnosis & therapy 17, 165-184, doi:10.1007/s40291-013-0028-5 (2013).
  9. Rost, S. et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427, 537-541, doi:10.1038/nature02214 (2004).